Life Science

Novo Nordisk sues Lilly, claiming misleading ads in weight-loss drug battle - July 2026

LONDON, July 21 (Reuters) - Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform Novo's drugs.

Reuters

Jul 22, 2026

Economics & Finance

Showing of 552 posts

Novo Nordisk sues Lilly, claiming misleading ads in weight-loss drug battle - July 2026

Featured posts

Commodity Desk - If Hormuz Reopens, the Barrels Will Still Lag: Why Oil’s Peace Trade Could Overshoot

Energy Matrix - California Curtailed 4.5 Billion kWh of Green Electricity in Six Months. Why Is It Still Worried About Power Shortages?

Silicon Bakery - How Intensified Will the AI Infra Race Be? Behind: Intel's Capital Raising, Nvidia's AI Funding Plan, Microsoft's Bet on Indigenous Chips And More...

Breaking News - DeepSeek foreshadows significant API price increases? Amid off the chart usage - Aug 6, 2026

Market Rumor - Apple is not get a favor on pricing with CXMT?

Tags